1. Home
  2. BDTX vs SSSS Comparison

BDTX vs SSSS Comparison

Compare BDTX & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • SSSS
  • Stock Information
  • Founded
  • BDTX 2014
  • SSSS 2010
  • Country
  • BDTX United States
  • SSSS United States
  • Employees
  • BDTX N/A
  • SSSS N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • SSSS Finance: Consumer Services
  • Sector
  • BDTX Health Care
  • SSSS Finance
  • Exchange
  • BDTX Nasdaq
  • SSSS Nasdaq
  • Market Cap
  • BDTX 144.9M
  • SSSS 143.5M
  • IPO Year
  • BDTX 2020
  • SSSS N/A
  • Fundamental
  • Price
  • BDTX $2.20
  • SSSS $6.34
  • Analyst Decision
  • BDTX Strong Buy
  • SSSS Buy
  • Analyst Count
  • BDTX 4
  • SSSS 2
  • Target Price
  • BDTX $15.50
  • SSSS $6.00
  • AVG Volume (30 Days)
  • BDTX 1.2M
  • SSSS 204.0K
  • Earning Date
  • BDTX 03-11-2025
  • SSSS 03-12-2025
  • Dividend Yield
  • BDTX N/A
  • SSSS N/A
  • EPS Growth
  • BDTX N/A
  • SSSS N/A
  • EPS
  • BDTX N/A
  • SSSS N/A
  • Revenue
  • BDTX N/A
  • SSSS $5,903,895.00
  • Revenue This Year
  • BDTX N/A
  • SSSS N/A
  • Revenue Next Year
  • BDTX N/A
  • SSSS N/A
  • P/E Ratio
  • BDTX N/A
  • SSSS N/A
  • Revenue Growth
  • BDTX N/A
  • SSSS 5.43
  • 52 Week Low
  • BDTX $1.91
  • SSSS $3.32
  • 52 Week High
  • BDTX $7.66
  • SSSS $6.74
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 46.41
  • SSSS 61.68
  • Support Level
  • BDTX $2.02
  • SSSS $5.59
  • Resistance Level
  • BDTX $2.33
  • SSSS $6.74
  • Average True Range (ATR)
  • BDTX 0.18
  • SSSS 0.28
  • MACD
  • BDTX 0.03
  • SSSS 0.03
  • Stochastic Oscillator
  • BDTX 38.16
  • SSSS 65.22

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About SSSS SuRo Capital Corp.

SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.

Share on Social Networks: